Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q1 2026
Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 514
- +134 vs. Q4 2025
- Shares held
- 198.3M
- +18.1M (+10.1%) vs. Q4 2025
- Total value
- $19.1B
- +$4.71B (+32.9%) vs. Q4 2025
- New holders
- 172
- 165 more added
- Sold out
- 38
- 127 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Raymond James Financial Inc | 137,160 | $13.3M | 0.00% | −107,014−43.8% | Reduced |
| PSquared Asset Management AG | 138,290 | $13.4M | 4.68% | +138,290 | New |
| Amundi | 138,560 | $13.5M | 0.00% | +118,493+590.5% | Added |
| PFM Health Sciences, LP | 140,770 | $13.7M | 1.44% | −10,683−7.1% | Reduced |
| Manufacturers Life Insurance Company, The | 141,296 | $13.7M | 0.01% | −30,247−17.6% | Reduced |
| Victory Capital Management Inc | 142,578 | $13.9M | 0.01% | +3,266+2.3% | Added |
| State Board of Administration of Florida Retirement System | 144,882 | $14.1M | 0.03% | +13,946+10.7% | Added |
| Birnam Oak Advisors, LP | 159,413 | $15.5M | 4.27% | +159,413 | New |
| Ikarian Capital, LLC | 163,142 | $15.9M | 2.27% | +25,000+18.1% | Added |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 164,988 | $16.0M | 0.01% | +133,474+423.5% | Added |
| California State Teachers Retirement System | 165,277 | $16.1M | 0.02% | +29,887+22.1% | Added |
| Rhumbline Advisers | 179,942 | $17.5M | 0.01% | +19,494+12.1% | Added |
| Baillie Gifford & Co | 187,072 | $18.2M | 0.02% | −7,887−4.0% | Reduced |
| Abu Dhabi Investment Council Co P.J.S.C | 1,739,859 | $19.1M | 1.97% | +1,739,859 | New |
| Fisher Asset Management, LLC | 215,947 | $21.0M | 0.01% | −25,110−10.4% | Reduced |
| Marshall Wace, LLP | 216,661 | $21.1M | 0.02% | −169,530−43.9% | Reduced |
| Marsico Capital Management LLC | 219,460 | $21.3M | 0.63% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 227,940 | $22.2M | 0.04% | −7,868−3.3% | Reduced |
| Frontier Capital Management Co LLC | 243,804 | $23.7M | 0.24% | −186,964−43.4% | Reduced |
| Trails Edge Capital Partners, LP | 245,000 | $23.8M | 5.61% | +245,000 | New |
| Perceptive Advisors LLC | 258,600 | $25.1M | 0.50% | +258,600 | New |
| Nicholas Investment Partners, LP | 261,166 | $25.4M | 1.83% | −56,545−17.8% | Reduced |
| Eventide Asset Management, LLC | 261,425 | $25.4M | 0.42% | −116,836−30.9% | Reduced |
| Checkpoint Capital L.P. | 262,539 | $25.5M | 9.16% | −107,461−29.0% | Reduced |
| Melqart Asset Management (UK) Ltd | 270,363 | $26.3M | 2.59% | +270,363 | New |
| Sumitomo Mitsui Trust Holdings, Inc. | 270,972 | $26.4M | 0.02% | +265,474+4,828.6% | Added |
| Man Group plc | 275,270 | $26.8M | 0.06% | +177,765+182.3% | Added |
| StemPoint Capital LP | 281,632 | $27.4M | 5.26% | +219,600+354.0% | Added |
| California Public Employees Retirement System | 281,960 | $27.4M | 0.02% | −9,046−3.1% | Reduced |
| JPMorgan Chase & Co | 301,393 | $27.9M | 0.00% | −120,234−28.5% | Reduced |
| Jennison Associates LLC | 307,377 | $29.9M | 0.02% | +2,117+0.7% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 315,860 | $30.7M | 1.05% | +315,860 | New |
| Defilade Capital Management, L.P. | 315,972 | $30.7M | 4.31% | −47,482−13.1% | Reduced |
| TD Asset Management Inc | 317,811 | $30.9M | 0.03% | −52,709−14.2% | Reduced |
| American Century Companies Inc | 335,528 | $32.6M | 0.02% | −131,832−28.2% | Reduced |
| Nuveen, LLC | 340,611 | $33.1M | 0.01% | −65,630−16.2% | Reduced |
| Legal & General Group Plc | 341,148 | $33.2M | 0.01% | +187,768+122.4% | Added |
| Mass General Brigham, Inc | 344,091 | $33.5M | 7.14% | 00.0% | Unchanged |
| Voloridge Investment Management, LLC | 368,325 | $35.8M | 0.14% | +46,036+14.3% | Added |
| Royal Bank of Canada | 371,743 | $36.2M | 0.01% | −131,978−26.2% | Reduced |
| Samlyn Capital, LLC | 371,948 | $36.2M | 0.62% | +371,948 | New |
| Millennium Management LLC | 377,332 | $36.7M | 0.03% | −422,786−52.8% | Reduced |
| Barclays PLC | 383,179 | $37.3M | 0.01% | +247,131+181.6% | Added |
| Invesco Ltd. | 392,844 | $38.2M | 0.00% | +24,993+6.8% | Added |
| Citadel Advisors LLC | 400,053 | $38.9M | 0.03% | −902,308−69.3% | Reduced |
| BNP Paribas Arbitrage, SA | 422,443 | $41.1M | 0.03% | −196,944−31.8% | Reduced |
| Swiss National Bank | 425,431 | $41.4M | 0.02% | +149,100+54.0% | Added |
| Boothbay Fund Management, LLC | 438,595 | $42.7M | 1.00% | +111,443+34.1% | Added |
| Deutsche Bank AG | 465,758 | $45.3M | 0.01% | +433,541+1,345.7% | Added |
| First Turn Management, LLC | 468,376 | $45.5M | 5.09% | −170,009−26.6% | Reduced |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 479,080 | $46.6M | 3.95% | +479,080 | New |
| Boxer Capital Management, LLC | 500,000 | $48.6M | 6.38% | +100,000+25.0% | Added |
| UBS Asset Management Americas Inc | 500,595 | $48.7M | 0.01% | +151,183+43.3% | Added |
| MPM Oncology Impact Management LP | 506,776 | $49.3M | 3.81% | +1,104+0.2% | Added |
| Lunate Capital Ltd | 549,050 | $53.4M | 44.36% | −1,647,150−75.0% | Reduced |
| Pictet Asset Management Holding SA | 557,560 | $53.6M | 0.06% | −579,561−51.0% | Reduced |
| Qube Research & Technologies Ltd | 553,290 | $53.8M | 0.08% | +553,290 | New |
| TCG Crossover Management, LLC | 576,473 | $56.1M | 1.60% | +140,000+32.1% | Added |
| Candriam Luxembourg S.C.A. | 580,677 | $56.5M | 0.29% | −450,315−43.7% | Reduced |
| DAFNA Capital Management LLC | 580,678 | $56.5M | 12.85% | −23,836−3.9% | Reduced |
| Bank of America Corp | 614,157 | $59.7M | 0.00% | −265,688−30.2% | Reduced |
| Worldquant Millennium Advisors LLC | 622,304 | $60.5M | 0.23% | +528,294+562.0% | Added |
| Bank of New York Mellon Corp | 635,366 | $61.8M | 0.01% | +93,297+17.2% | Added |
| T. Rowe Price Investment Management, Inc. | 664,047 | $64.6M | 0.04% | −1,536,329−69.8% | Reduced |
| Frazier Life Sciences Management, L.P. | 675,686 | $65.7M | 1.69% | −121,769−15.3% | Reduced |
| Nearwater Capital Markets, Ltd | 678,000 | $65.9M | 1.56% | +678,000 | New |
| Morgan Stanley | 705,793 | $68.6M | 0.00% | +54,061+8.3% | Added |
| General Atlantic LLC | 707,791 | $68.8M | 3.20% | −2,105,137−74.8% | Reduced |
| MIC Capital Management UK LLP | 795,733 | $77.4M | 21.95% | +287,164+56.5% | Added |
| AIHC Capital Management Ltd | 828,974 | $80.6M | 67.37% | −71,418−7.9% | Reduced |
| Dimensional Fund Advisors LP | 844,614 | $82.1M | 0.02% | −317,032−27.3% | Reduced |
| AH Capital Management, L.L.C. | 921,099 | $89.6M | 6.94% | 00.0% | Unchanged |
| Northern Trust Corp | 954,256 | $92.8M | 0.01% | +103,933+12.2% | Added |
| D. E. Shaw & Co., Inc. | 1,022,298 | $99.4M | 0.08% | −591,432−36.6% | Reduced |
| Siren, L.L.C. | 1,110,980 | $108.0M | 3.00% | −224,095−16.8% | Reduced |
| Vanguard Fiduciary Trust Co | 1,133,319 | $110.2M | 0.03% | +1,133,319 | New |
| Franklin Resources Inc | 1,133,546 | $110.2M | 0.03% | +73,375+6.9% | Added |
| Polar Capital Holdings Plc | 1,133,930 | $110.3M | 0.48% | −879,861−43.7% | Reduced |
| Rock Springs Capital Management LP | 1,209,465 | $117.6M | 6.93% | −125,805−9.4% | Reduced |
| Integral Health Asset Management, LLC | 1,500,000 | $145.9M | 7.72% | +300,000+25.0% | Added |
| Bellevue Group AG | 1,544,456 | $150.2M | 3.57% | −3,461,263−69.1% | Reduced |
| Westfield Capital Management Co LP | 1,556,578 | $151.4M | 0.64% | −1,288,435−45.3% | Reduced |
| Two Sigma Investments, LP | 1,558,807 | $151.6M | 0.13% | +1,137,072+269.6% | Added |
| Ameriprise Financial Inc | 1,579,793 | $153.6M | 0.04% | −477,064−23.2% | Reduced |
| Caligan Partners LP | 1,652,808 | $160.7M | 11.37% | +368,908+28.7% | Added |
| Charles Schwab Investment Management Inc | 1,735,476 | $168.8M | 0.03% | +51,747+3.1% | Added |
| National Bank of Canada | 1,749,000 | $170.1M | 0.17% | +1,749,000 | New |
| Alyeska Investment Group, L.P. | 1,885,821 | $183.4M | 0.52% | +1,646,724+688.7% | Added |
| Logos Global Management LP | 2,000,000 | $194.5M | 10.02% | 00.0% | Unchanged |
| Darwin Global Management, Ltd. | 2,211,018 | $205.0M | 5.44% | +2,211,018 | New |
| Goldman Sachs Group Inc | 2,185,500 | $212.5M | 0.03% | −306,083−12.3% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 2,297,000 | $223.4M | 2.64% | −597,613−20.6% | Reduced |
| Avoro Capital Advisors LLC | 2,344,444 | $228.0M | 2.25% | +174,444+8.0% | Added |
| Vestal Point Capital, LP | 2,375,000 | $231.0M | 6.46% | +2,080,000+705.1% | Added |
| Holocene Advisors, LP | 2,468,644 | $240.1M | 0.58% | +560,696+29.4% | Added |
| Woodline Partners LP | 2,506,570 | $243.8M | 0.92% | +5,675+0.2% | Added |
| Casdin Capital, LLC | 2,577,333 | $250.6M | 18.98% | 00.0% | Unchanged |
| BVF Inc | 2,856,782 | $277.8M | 8.85% | −500,000−14.9% | Reduced |
| Price T Rowe Associates Inc | 3,232,213 | $314.3M | 0.04% | −172,504−5.1% | Reduced |
| Alphabet Inc. | 3,292,525 | $320.2M | 7.97% | −52,577−1.6% | Reduced |